Covered recipient · General Payments record
ANN LOTTES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,797.62
- Reported across 101 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $350.28 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $136.38 | 8 |
| PFIZER INC. | $64.29 | 4 |
| ABBVIE INC. | $53.71 | 2 |
| Astellas Pharma US Inc | $21.76 | 1 |
| Amgen Inc. | $20.53 | 1 |
| Lilly USA, LLC | $20.52 | 1 |
| Abbott Laboratories | $16.84 | 1 |
| Phadia US Inc. | $16.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.84 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125137939 | CMS |
| ABBVIE INC. | $32.15 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104903384 | CMS |
| ABBVIE INC. | $21.56 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104903386 | CMS |
| Amgen Inc. | $20.53 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111637808 | CMS |
| Astellas Pharma US Inc | $21.76 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139402497 | CMS |
| Lilly USA, LLC | $20.52 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136056124 | CMS |
| Novo Nordisk Inc | $16.18 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097682851 | CMS |
| Novo Nordisk Inc | $16.53 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097439306 | CMS |
| Novo Nordisk Inc | $8.06 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097614627 | CMS |
| Novo Nordisk Inc | $18.93 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097719414 | CMS |
| Novo Nordisk Inc | $23.31 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097541526 | CMS |
| Novo Nordisk Inc | $17.94 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097460854 | CMS |
| Novo Nordisk Inc | $23.05 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097584915 | CMS |
| Novo Nordisk Inc | $12.38 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096990063 | CMS |
| PFIZER INC. | $14.05 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131026051 | CMS |
| PFIZER INC. | $15.49 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131710569 | CMS |
| PFIZER INC. | $15.35 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131684855 | CMS |
| PFIZER INC. | $19.40 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130881568 | CMS |
| Phadia US Inc. | $16.25 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067575696 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.